Estimating the effectiveness of acellular pertussis vaccines

Clinical Infectious Diseases

Volumn 55, Issue 10, 2012, Pages 1432-1433

  Misegades, Lara K ^a   Martin, Stacey W ^a   Messonnier, Nancy E ^a   Clark, Thomas A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

CLINICAL PRACTICE; DRUG EFFICACY; GROUPS BY AGE; HUMAN; INFECTION PREVENTION; INFECTION RISK; LETTER; PERTUSSIS; PRIORITY JOURNAL;

DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 84868035002     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis669     Document Type: Letter

References (3)

1. Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012; 54:1730-5.
2. OrensteinWA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988; 10:212-41.
3. Guris D, Strebel PM, Tachdjian R, Bardenheier B, Wharton M, Hadler SC. Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994. J Infect Dis 1997; 176:456-63.